SEC Form 4 · accession 0001209191-19-014766
METLIFE INC · MET
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ramy Tadros
Officer — EVP & Chief Risk Officer
Period of report
Feb 26, 2019
Accepted (ET)
Feb 28, 2019 · 6:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099219
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $44.65 | Feb 26, 2019 | A | 20,162 | A | — | Feb 25, 2029 | Common Stock | 20,162 | 20,162 | D |
| Restricted Stock UnitsF2,F3 | — | Feb 26, 2019 | A | 6,719 | A | — | — | Common Stock | 6,719 | 6,719 | D |
Explanation of responses
- F1The options become exercisable in three installments on February 26, 2020, 2021 and 2022.
- F2Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock.
- F3The Restricted Stock Units vest in three installments on March 2, 2020, March 1, 2021 and March 1, 2022.